Wear it pink this October Wear pink. Raise money. Help make life-changing breast cancer research and support happen.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 209 results We respond to research about the benefits of exercise 18 Nov 2022 1 min read We respond to research about radiotherapy and long-term breast cancer survival 18 Nov 2022 1 min read We respond to research about women with benign breast disease being at higher risk of breast cancer in the long term 17 Nov 2022 1 min read We respond to latest NHSE Cancer Wait Times data 11 Nov 2022 1 min read We respond to NICE’s devastating decision to provisionally reject the use of olaparib on the NHS 10 Nov 2022 2 min read We respond to the launch of the first UK proton beam therapy trial for breast cancer patients 03 Jan 2023 1 min read We respond to new estimates that 57,215 people were living with secondary (metastatic) breast cancer in England in 2020 to 2021 22 Dec 2022 2 min read We respond to NICE’s approval of trastuzumab deruxtecan (Enhertu) for use on the Cancer Drugs Fund 20 Dec 2022 1 min read We respond to double SMC drug announcement - adjuvant abemaciclib and alpelisib with fulvestrant 12 Dec 2022 2 min read Pembrolizumab in combination with chemo is approved for use on the NHS in Scotland 10 Oct 2022 1 min read We respond to research about a potential new treatment for advanced breast cancer patients 08 Dec 2022 1 min read Breast Cancer Now responds to latest NHSE Cancer Wait Times data, calling for the FDS to be raised to 95% 13 Oct 2022 1 min read Previous 1 ... 10 ... 18 Next
We respond to research about radiotherapy and long-term breast cancer survival 18 Nov 2022 1 min read
We respond to research about women with benign breast disease being at higher risk of breast cancer in the long term 17 Nov 2022 1 min read
We respond to NICE’s devastating decision to provisionally reject the use of olaparib on the NHS 10 Nov 2022 2 min read
We respond to the launch of the first UK proton beam therapy trial for breast cancer patients 03 Jan 2023 1 min read
We respond to new estimates that 57,215 people were living with secondary (metastatic) breast cancer in England in 2020 to 2021 22 Dec 2022 2 min read
We respond to NICE’s approval of trastuzumab deruxtecan (Enhertu) for use on the Cancer Drugs Fund 20 Dec 2022 1 min read
We respond to double SMC drug announcement - adjuvant abemaciclib and alpelisib with fulvestrant 12 Dec 2022 2 min read
Pembrolizumab in combination with chemo is approved for use on the NHS in Scotland 10 Oct 2022 1 min read
We respond to research about a potential new treatment for advanced breast cancer patients 08 Dec 2022 1 min read
Breast Cancer Now responds to latest NHSE Cancer Wait Times data, calling for the FDS to be raised to 95% 13 Oct 2022 1 min read
